Hydroxocobalamin
FDA status: FDA has approved products that contain hydroxocobalamin, including Cyanokit.
PubMed: 1,108 publications mention Hydroxocobalamin, 27 of them trials or reviews. Search PubMed
- Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue. Brokmeier HM et al. Journal of cardiothoracic and vascular anesthesia, 2023. Meta-Analysis, Systematic Review. PMID 37147207 · DOI
- Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials. Kotani Y et al. Critical care (London, England), 2024. Meta-Analysis, Systematic Review. PMID 39736782 · DOI
- ADJUNCTIVE VASOPRESSORS AND SHORT-TERM MORTALITY IN ADULTS WITH SEPTIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS. Bauer SR et al. Shock (Augusta, Ga.), 2025. Systematic Review, Meta-Analysis. PMID 39965613 · DOI
- Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management. Datt V et al. Journal of cardiac surgery, 2021. Systematic Review. PMID 34251716 · DOI
- High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial). Patel JJ et al. Chest, 2023. Randomized Controlled Trial, Clinical Trial, Phase II. PMID 36174744 · DOI
ClinicalTrials.gov: 745 registered studies. See all studies
FDA label (DailyMed) ↗RxNorm 5514 ↗PubChem CID 44475014 ↗Wikipedia ↗









